MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters - Greece
doi 10.3892/ol.2017.5574
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research
Oncology
2019English

miRNA-378 Reverses Chemoresistance to Cisplatin in Lung Adenocarcinoma Cells by Targeting Secreted Clusterin

Scientific Reports
Multidisciplinary
2016English

Inhibitor of DNA Binding 3 Reverses Cisplatin Resistance in Human Lung Adenocarcinoma Cells by Regulating the PI3K/Akt Pathway

Oncology Letters
Cancer ResearchOncology
2018English

ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2018English

MicroRNA‑506‑3p Reverses Gefitinib Resistance in Non‑small Cell Lung Cancer by Targeting Yes‑associated Protein 1

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

MiR-134/487b/655 Cluster Regulates TGF- -Induced Epithelial-Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting MAGI2 in Lung Adenocarcinoma Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Silibinin Reverses Drug Resistance in Human Small-Cell Lung Carcinoma Cells

Cancer Letters
Cancer ResearchOncology
2013English

Erratum To: MicroRNA-492 Reverses High Glucose-Induced Insulin Resistance in HUVEC Cells Through Targeting Resistin

Molecular and Cellular Biochemistry
MedicineClinical BiochemistryCell BiologyMolecular Biology
2014English

Furosemide Reverses Multidrug Resistance Status in Bladder Cancer Cells in Vitro

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy